Youngevity Forms Marketing Alliance with True2Life, Direct Seller of Science-based Personal Care and Wellness Products
Deal to expand Youngevity’s presence in Latin America and Southeast Asia
SAN DIEGO–(BUSINESS WIRE)–Growing direct-selling conglomerate Youngevity® Essential Life Sciences (www.Youngevity.com) announced today that it entered a marketing alliance with True2Life (www.true2life.com), a Brea, California-based direct seller of a unique line of all-natural personal care and wellness products. Youngevity is a wholly owned subsidiary of AL International (PINKSHEETS: JCOF) (www.alintjcof.com), a global marketer of lifestyle and nutritional products and services and gourmet coffee.
The agreement with True2Life is the latest step in the company’s long-term growth strategy through international expansion. “As a company whose mission is to improve the physical and financial health of its customers, True2Life has great synergies with Youngevity,” said Steve Wallach, CEO of AL International. “This new alliance adds to our momentum as we build a worldwide consumer cloud of friend-to-friend advertising for multiple products and services,” he added. As a result of the agreement, distributors and customers from both companies will have access to both companies’ products and services.
Founded in 2010 by Dr. Luis Arriaza, DC, True2Life offers premium, high-value, all-natural nutritional formulas to support weight management, energy production, detoxification and other health aspects. The company has customers in the United States, Mexico and the Philippines.
Dr. Luis and Evelia Arriaza will continue to participate actively with the company. “The Arriaza’s have energy and expertise that we consider priceless assets. We are thrilled to have the benefit of their involvement as we move forward,” said Wallach.
“We’re pleased to be able to offer our products through a market leader such as Youngevity,” said Dr. Arriaza. “Their mission, to improve the health and well-being of people throughout the world, aligns closely with our own and I believe these synergies will serve both our companies and customers well.”
About Youngevity® Essential Life Sciences
Youngevity Essential Life Sciences (www.Youngevity.com), headquartered in San Diego, CA, is a nutrition and lifestyle-related services company dedicated to promoting vibrant health and flourishing economics. Founded in 1997 by Drs. Joel Wallach, DVM, ND, and Ma Lan, MD, as AL Global, Inc., the company adopted the name Youngevity in 2006. Youngevity is the only network marketing company to have a qualified FDA Health Claim. Dr. Wallach’s work has been published in more than 70 peer-reviewed and referenced scientific journals and books.
About AL International
AL International, Inc. (PINKSHEETS: JCOF) (www.alintjcof.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a “network of networks.” The company also is a vertically integrated producer of the finest coffees for the commercial, retail and direct sales channels. AL International was formed after the merger of Youngevity Essential Life Sciences (www.Youngevity.com) and Javalution Coffee Company in the summer of 2011.
True2Life (www.true2life.com) is located in Brea, California, and was founded in 2010 by Dr. Luis Arriaza, DC. The company’s mission is to provide high-quality nutritional solutions at high-value prices while giving back as much as is possible to both the company’s associates, representatives and the community.
Safe Harbor Statement
This release includes forward-looking statements on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements relating to our business plan and growth strategy through acquisition. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in our forward-looking statements include, among others, the ability to implement our business plan and growth strategy through acquisition and the continued growth of our distributor base. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.